SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-23-003192
Filing Date
2023-10-11
Accepted
2023-10-11 16:30:10
Documents
13
Period of Report
2023-10-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea186465-8k_aditxt.htm   iXBRL 8-K 29754
2 FORM OF AGREEMENT FOR THE PURCHASE AND SALE OF FUTURE RECEIPTS ea186465ex10-1_aditxt.htm EX-10.1 184461
  Complete submission text file 0001013762-23-003192.txt   424098

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adtx-20231005.xsd EX-101.SCH 3018
4 XBRL LABEL FILE adtx-20231005_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE adtx-20231005_pre.xml EX-101.PRE 22361
7 EXTRACTED XBRL INSTANCE DOCUMENT ea186465-8k_aditxt_htm.xml XML 3395
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 231320972
SIC: 2834 Pharmaceutical Preparations